Cognizant Remains Appealing Despite Not-So-Appealing TriZetto Deal
- Cognizant is acquiring TriZetto to boost its healthcare offerings.
- The deal looks okay from a strategic point of view, yet the company is paying a steep price.
- Long-term growth, fair valuation, and a strong balance sheet remain attractive. I am a buyer on dips.